BRPI0416931A - processo para resolver ácidos mandélicos, e, composto - Google Patents

processo para resolver ácidos mandélicos, e, composto

Info

Publication number
BRPI0416931A
BRPI0416931A BRPI0416931-0A BRPI0416931A BRPI0416931A BR PI0416931 A BRPI0416931 A BR PI0416931A BR PI0416931 A BRPI0416931 A BR PI0416931A BR PI0416931 A BRPI0416931 A BR PI0416931A
Authority
BR
Brazil
Prior art keywords
mandelic acid
acid derivatives
alkyl
solving
compound
Prior art date
Application number
BRPI0416931-0A
Other languages
English (en)
Inventor
Hans Jorgen Blixt
Bo Lars Gustaf Bosson
Roberto Giuseppe Paolo Gatti
Michael Senior William
Simone Zaramella
Kurt Vogtli
Andrea Zistler
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of BRPI0416931A publication Critical patent/BRPI0416931A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/42Separation; Purification; Stabilisation; Use of additives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/16Preparation of optical isomers
    • C07C231/20Preparation of optical isomers by separation of optical isomers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/24Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/42Separation; Purification; Stabilisation; Use of additives
    • C07C51/487Separation; Purification; Stabilisation; Use of additives by treatment giving rise to chemical modification
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/58Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)

Abstract

"PROCESSO PARA RESOLVER ACIDOS MANDéLICOS E COMPOSTO". A presente invenção diz respeito a um novo processo para a resolução de derivados de ácido mandélico a partir de misturas de derivados de ácido mandélico racêmico pela formação de sal com amidas cíclicas de base quiral; para os sais de amida cíclica do ácido mandélico resolvidos (ver, por exemplo, a fórmula IIa) bem como certos outros sais de amina e metálicos dos derivados de ácido mandélico, e ao uso dos derivados de ácido mandélico resolvidos como intermediários apropriados para a fabricação em larga escala de, por exemplo, compostos farmacêuticos; A fórmula IIa, em que R é selecionado a de CHF~ 2~, H, Alquila C~ 1-6~, CH~ 2~F, CHC1~ 2~ e CC1F~ 2~; e em que n é 0, 1 ou 2; R1 é H ou Alquila C~ 1-6~ e X é H, halo ou Alquila C~ 1-6~.
BRPI0416931-0A 2003-11-28 2004-11-25 processo para resolver ácidos mandélicos, e, composto BRPI0416931A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0303220A SE0303220D0 (sv) 2003-11-28 2003-11-28 New process
PCT/GB2004/004964 WO2005054168A2 (en) 2003-11-28 2004-11-25 A process for resolving, optionally substituted, mandelic acids by salt formation with a chiral base cyclic amide

Publications (1)

Publication Number Publication Date
BRPI0416931A true BRPI0416931A (pt) 2007-01-16

Family

ID=29729226

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0416931-0A BRPI0416931A (pt) 2003-11-28 2004-11-25 processo para resolver ácidos mandélicos, e, composto

Country Status (15)

Country Link
US (1) US7960582B2 (pt)
EP (1) EP1692089A2 (pt)
JP (1) JP4906511B2 (pt)
KR (1) KR101134767B1 (pt)
CN (2) CN100448834C (pt)
AU (2) AU2004295152B2 (pt)
BR (1) BRPI0416931A (pt)
CA (1) CA2546694A1 (pt)
IL (1) IL175488A (pt)
NO (1) NO20062258L (pt)
NZ (1) NZ547354A (pt)
SE (1) SE0303220D0 (pt)
SG (2) SG148212A1 (pt)
WO (1) WO2005054168A2 (pt)
ZA (1) ZA200604192B (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR035216A1 (es) 2000-12-01 2004-05-05 Astrazeneca Ab Derivados de acido mandelico ,derivados farmaceuticamente aceptables, uso de estos derivados para la fabricacion de medicamentos, metodos de tratamiento ,procesos para la preparacion de estos derivados, y compuestos intermediarios
AR034517A1 (es) 2001-06-21 2004-02-25 Astrazeneca Ab Formulacion farmaceutica
SE0201661D0 (sv) * 2002-05-31 2002-05-31 Astrazeneca Ab New salts
US7781424B2 (en) * 2003-05-27 2010-08-24 Astrazeneca Ab Modified release pharmaceutical formulation
SE0303220D0 (sv) 2003-11-28 2003-11-28 Astrazeneca Ab New process
GB0510546D0 (en) * 2005-05-24 2005-06-29 Astrazeneca Ab New process
TW200827336A (en) 2006-12-06 2008-07-01 Astrazeneca Ab New crystalline forms
TW200900033A (en) * 2007-06-21 2009-01-01 Wen-Qing Li Automatic brewing machine
US20090061000A1 (en) * 2007-08-31 2009-03-05 Astrazeneca Ab Pharmaceutical formulation use 030
CN103450008B (zh) * 2013-09-02 2015-02-25 江苏宝众宝达药业有限公司 一种从废水中回收扁桃酸的方法
CN104447294A (zh) * 2014-11-24 2015-03-25 苏州乔纳森新材料科技有限公司 一种3-环己烯-1-甲酸的手性拆分方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1867274A (en) * 1929-11-20 1932-07-12 Lilly Co Eli Resolution of ephedrine and its homologues and of mandelic acid, and certain intermediates
JPS581105B2 (ja) * 1977-03-24 1983-01-10 日本化薬株式会社 光学活性アミノ酸−マンデル酸複合体及びその製造法
JPS5416442A (en) * 1977-07-08 1979-02-07 Sumitomo Chem Co Ltd Optical resolution of 3-pheoxymandelic acid
US4239912A (en) * 1978-12-08 1980-12-16 American Cyanamid Company Process for resolving DL-Mandelic acid with novel 2-benzylamino-1-butanols
US4260815A (en) * 1979-10-09 1981-04-07 American Cyanamid Company Process for preparing a solution of DL-mandelic acid
US4259521A (en) * 1979-10-09 1981-03-31 American Cyanamid Company Process for resolving DL-mandelic acid
JPH01221345A (ja) * 1988-02-27 1989-09-04 Ajinomoto Co Inc マンデル酸誘導体の光学分割方法
DE4137663A1 (de) * 1991-11-12 1993-05-13 Degussa Verfahren zur herstellung optisch aktiver 1,3-imidazolidin-4-one und deren verwendung
JPH11228546A (ja) * 1998-02-09 1999-08-24 Koei Chem Co Ltd 光学活性2−(N−tert−ブチルカルバモイル)ピペラジンの製造法
JP2001002641A (ja) * 1999-06-24 2001-01-09 Daito Chemix Corp 光学活性3−アミノピロリジン−2−オン誘導体の製造法
JP2001072644A (ja) * 1999-09-06 2001-03-21 Yamakawa Yakuhin Kogyo Kk 光学活性な2−クロロマンデル酸の製造方法および製造の中間体
EP1236714B1 (en) 1999-11-29 2007-01-17 Mitsubishi Rayon Co., Ltd. Acetalsulfonate derivative, process for producing the same, and process for producing styrene oxide derivative
WO2002068391A1 (en) 2000-11-20 2002-09-06 Eli Lilly And Company Process for resolving racemic mixtures of piperidine derivatives
AR035216A1 (es) * 2000-12-01 2004-05-05 Astrazeneca Ab Derivados de acido mandelico ,derivados farmaceuticamente aceptables, uso de estos derivados para la fabricacion de medicamentos, metodos de tratamiento ,procesos para la preparacion de estos derivados, y compuestos intermediarios
US7129233B2 (en) 2000-12-01 2006-10-31 Astrazeneca Ab Mandelic acid derivatives and their use as thrombin inhibitors
AR034517A1 (es) * 2001-06-21 2004-02-25 Astrazeneca Ab Formulacion farmaceutica
SE0303220D0 (sv) 2003-11-28 2003-11-28 Astrazeneca Ab New process
GB0503672D0 (en) 2005-02-23 2005-03-30 Astrazeneca Ab New process
GB0510546D0 (en) 2005-05-24 2005-06-29 Astrazeneca Ab New process

Also Published As

Publication number Publication date
CA2546694A1 (en) 2005-06-16
SE0303220D0 (sv) 2003-11-28
KR20060109965A (ko) 2006-10-23
SG148213A1 (en) 2008-12-31
JP4906511B2 (ja) 2012-03-28
KR101134767B1 (ko) 2012-04-13
EP1692089A2 (en) 2006-08-23
CN1886359A (zh) 2006-12-27
WO2005054168A2 (en) 2005-06-16
CN100448834C (zh) 2009-01-07
IL175488A (en) 2012-02-29
NZ547354A (en) 2010-02-26
ZA200604192B (en) 2007-11-28
NO20062258L (no) 2006-08-23
WO2005054168A3 (en) 2005-10-27
AU2004295152A1 (en) 2005-06-16
US7960582B2 (en) 2011-06-14
JP2007513885A (ja) 2007-05-31
AU2004295152B2 (en) 2009-07-02
IL175488A0 (en) 2006-09-05
US20080312457A1 (en) 2008-12-18
SG148212A1 (en) 2008-12-31
AU2009208107A1 (en) 2009-09-03
CN101407453A (zh) 2009-04-15

Similar Documents

Publication Publication Date Title
BRPI0416931A (pt) processo para resolver ácidos mandélicos, e, composto
HRP20040690B1 (en) Novel fluorene carboxylic acid esters, methods for the production thereof, and use of the same as pharmaceuticals
EA201490831A1 (ru) Способ получения хинолиновых производных
BR0315335A (pt) Processo para a preparação de (s,s)-cis-2-benzidril-3-benzilaminoquinuclina
AR049401A1 (es) Aza-biciclononanos
EP1712549A4 (en) OPTICALLY ACTIVE QUATERNARY AMMONIUM SALT HAVING AXIAL ASYMMETRY AND PROCESS FOR PRODUCTION OF ALPHA-AMINO ACID AND ITS DERIVATIVE THEREOF
BR112023005509A2 (pt) Um processo para a síntese de compostos de amida/ácido antranílico e intermediários dos mesmos
NO20075625L (no) Fremgangsmate for dynamisk opplosning av (substituert) (R)- eller (S) -mandelsyre
BR112023025104A2 (pt) Um processo inovador para a preparação de diamidas antranílicas
BR0308280A (pt) Compostos oxo-azabicìclicos
AR048465A1 (es) Derivados de acidos carboxilicos
BRPI0408160B1 (pt) Processo para o preparo de ésteres do ácido nicotínico substituído e intermediários de enamina para uso nesse processo
DE602006008962D1 (de) Verfahren zur herstellung von valsartan
AR074630A1 (es) Proceso para preparar acidos 1-hidroxialquiliden-1,1-bifosfonicos
BRPI0500590B8 (pt) processo para a síntese de compostos de 1,3,4,5-tetraidro-2h-3-benzazepin-2-ona, e aplicação na síntese de ivabradina e sais de adição desta com um ácido farmaceuticamente aceitável
BRPI0409016A (pt) processos para preparação de um produto de reação, de uma composição farmacêutica, de uma composição agroquìmica, de uma composição de limpeza, de uma composição de tinta e de um refrigerante ou lubrificante
BRPI0513299A (pt) processo para preparação de ésteres de ácido 4, 4-difluoro-3-oxobutanóico
BR0214863A (pt) Processo para a sìntese de beta-aminoálcoois quiralmente puros
AR075441A1 (es) Un proceso para la preparacion de etoricoxib
BR0314954A (pt) Derivados cìclicos de ácido nitrometilacético
BRPI0516192A (pt) composto, e, método para a preparação de um composto
ATE455088T1 (de) Asymmetrische reduktive aminierung von ketosäurederivaten zur herstellung von aminosäurederivaten
AR126158A1 (es) Proceso de una sola etapa para la preparación de un aminoácido quiral
AR044341A1 (es) Proceso para la sintesis de intermediarios de inhibidores de betalactamasa
BR112013018809B8 (pt) Método para produção de um derivado de ácido amido carboxílico aromático e derivado haleto de amida aromática

Legal Events

Date Code Title Description
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B11D Dismissal acc. art. 38, par 2 of ipl - failure to pay fee after grant in time